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CHAPTER I
INTRODUCTION
Amygdalin has been used as an anticancer agent for many centuries.

Dating back to circa 2800 B.C., during the reign of China's

Emperor Shen Nung, the apricot kernel and other amygdalin bearing
plants were used for cancer treatment (Halstead, 1977).

In England,

during the seventeenth century, apricot oil was used against tumors
or swellings of ulcers (Lewis and Elvin-Lewis, 1977).

In a study

sponsored by the National Cancer Institute, Wodinsky and Swiniarski
(1975) state that "amygdalin found in the kernels of bitter almonds,
peaches, and apricots, has been used in cancer chemotherapy since
1845."

Currently pure amygdalin, isolated from apricot kernels, is

being used, legally in many foreign countries and in many states of
the United States.
Amygdalin is one of the most widely distributed cyanogenic glycosides.

It is commonly found in members of the Rosaceae (rose family)

(Lewis and Elvin-Lewis, 1977).

Amygdalin is also known variously as

nitrilosides, Laetrile, or Vitamin B17·

Upon hydrolysis of amygdalin,

a two-step process, two molecules of glucose are released as well as
benzaldehyde, and hydrocyanic acid (Montgomery, 1969).

In 1950 Ernst

T. Krebs, Jr. theorized that it was the hydrogen cyanide released from
amygdalin that exerted its antineoplastic effects on cancer cells
1
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(Griffin, 1974).
The exact mechanism of action of amygdalin is not known, but
several hypotheses have been presented (Halstead, 1977).

The most

widespread theory on the action of amygdalin has been forwarded by
Ernst T. Krebs, Sr. and Jr ..

According to them, amygdalin is broken

down in the body by enzymes, and it is due to varying concentrations
of those enzymes that it has a specific effect.

Cancer cells have

high levels of the enzymes B-glucosidase and B-glucuronidase which
break down amygdalin and liberate hydrogen cyanide (Fishman andAnlyan,
1947; Haisman and Knight, 1967; Culbert, 1974; Krebs, 1967, 1970).
According to the Krebs' theory it is the high concentration of Bglucuronidase found in cancer cells that allows for the selective release of hydrogen cyanide from the amygdalin at the cancer site (Krebs,
1970).

Normal cells are protected from the hydrogen cyanide by the

presence of the enzyme rhodanese which converts hydrocyanic acid to
thiocyanate (Mendel, Rudney and Bowman, 1946; Giordano et al., 1956;
Oke, 1969).

Hydrolysis of amygdalin is a two-step oxidative process

and its occurence in the body has not been established scientifically.
Much of the Krebs' "cyanide theory" is based upon work done
previously by Beard (1902).

According to Beard's "Trophoblastic

Thesis of Cancer", the cancer cell is the same as the trophoblast cell
in pregnancy.

In some instances, however, the trophoblast cell,

which is normal during pregnancy, becomes misguided and under the influence of the sex hormone estrogen is transformed into a malignant
cell.

After further investigation of Beard's theory, Krebs et al.
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(1950) published a paper indicating that the trophoblast cell in pregnancy was inhibited by pancreatic enzymes and they inferred that the
trophoblast cell outside of pregnancy (the malignant cell) should also
be inhibited by the pancreatic enzymes.

Krebs, Jr. experimented fur-

ther with the use of pancreatic enzymes against cancer, and he claimed
to have had some positive results using chymotrypsin, but he noted
that it lacked the force to do the specific job that Beard had attributed to it in his theory (Culbert, 1974).

So, Krebs, Jr. continued

with his research in this area, which ultimately led him to the formulation of an extract from apricots, which he called "Laetrile".
Currently, amygdalin is being used in the form of Krebs'
Laetrile.

Krebs, Jr. first reported in 1950 that he had synthesized

this compound from the apricot kernel (Griffin, 1974) .
with the word Laetrile since it was derived from a
and subsequently patented the compound.

He came up

laevorotarynitrile

The main difference betwen

amygdalin and Laetrile is that amygdalin contains 2 glucose molecules
and Laetrile has only one.
In addition to therapeutic use, it has been proposed by proponents of amygdalin that by maintaining an adequate level of amygdalin
in one's diet, it will have a specific cancer preventative and controlling effect (Krebs, 1970; Larson, 1972; Griffin, 1974; Culbert, 1974).
The theory that amygdalin actually prevents or retards the growth of
cancer cells is based on two lines of reasoning.

One is that doctors

who have used nitrilosides on thousands of patients are enthusiastic
about the results.

They do not claim that it cures cancer, only that
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in many instances it halts the deadly progress of the disease.

The

other line of reasoning is that so-called primitive peoples, in whom
most forms of cancer are extremely rare, eat a diet containing a large
amount of amygdalin.

Conversely, in nations where cancer is near the

top of the killer list, the diet contains very little or no nitrilesides (Krebs, 1967; Larson, 1972; Griffin, 1974).
Experimental evidence to support the theory that amygdalin is
cancer preventive is somewhat limited, however it is still used by
many people throughout the world for that purpose.

A report by Stock

et al. (1978) indicates that in mice injected intraperitoneally with
amygdalin at a dosage of 1000 mg/kg/day, 17% developed lung metastases
and 72% tumors.

In the control group, 81% developed lung metastases

and 82% tumors.

In France, Metianu (1977) treated mice subcutaneous-

ly two to three times per week with 500 mg/kg of amygdalin after innoculating them with 5 x 10 8 cells of adenocarcinoma.

The experimental

group lived an average of 58 days past the time of tumor take and the
controls survived an average of 21 days.

In West Germany it was found

that in mice with Ehrlich Ascites Carcinoma, bitter almonds given in
addition to standard feed in a free food choice caused a significant
prolongation of survival time, which could be associated with inhibition of tumor growth (Reitnauer, 1974).

Manner et al. (1978), reports

that when amygdalin is used in conjunction with megadoses of Vitamin
A and certain enzymes, there is complete regression of primarymammary
tumors in C3H/HeJ mice in 89.3% of the cases.

No study has been done

on the effects of naturally occurring amygdalin (apricot kernels) on
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the prevention of spontaneous mammary tumors in female C3H/HeJ mice.
Although many toxicity studies on amygdalin have been carried
out, they lack uniformity.

Trube-Becker (1965) estimated that 50-70

raw almond kernels would have to be eaten to provide a lethal dose to
adults and as few as 7-10 almonds for a child.

Burk (1971) found that

amygdalin in doses as high as 10 gm/kg were non-toxic to adult animals.
Amygdalin administered intramuscularly in doses ranging from 1000-2500
mg/kg for 15 days was found to be non-toxic (Manner, DiSanti and
Michalsen, 1977).

Hill~

al. (1976) reported no toxicity with doses

ranging from 50 to 500 mg/kg for 4 days, but when doses reached 2000
mg/kg for 4 days there was a five percent death rate.

Amygdalin MF

used by Wodinsky and Swiniarski (1975) at 800 mg/kg intraperitoneally,
on mice for nine days showed no toxic effects.

However, Khandekar and

Edelman (1979) indicate that amygdalin given to Fischer 344 rats in
doses of 250, 500, and 750 mg/kg intraperitoneally daily for five days
caused mortalities of 30.8%, 44.1%, and 56.8% respectively.

There are

also a number of articles in the literature associating fatal cyanide
poisoning with the ingestion of amygdalin (Pijoan, 1942; Sayre and
Kaymakcalan, 1964; Townsend and Bani, 1975; Humbert et al., 1977;
Sadoff et al., 1978).

More recently though, it was reported that six

patients receiving Laetrile either intravenously or orally experienced
no toxic effects that could be directly ascribed to Laetrile therapy
(Henney, 1980).

Certainly, it is evident that the question of amyg-

dalin toxicity is unclear.
The purpose of the present study is to evaluate the importance
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of naturally occurring amygdalin (apricot kernels) in the prevention
of spontaneous mammary tumors in female C3H/HeJ mice and to look at
its effects on longevity and the time required for initial tumor appearance.

This study will also look for any possible toxic effects

when amygdalin is administered by this route.

CHAPTER II
REVIEW OF RELATED LITERATURE
AHYGDALIN
Amygdalin belongs to a family of compounds known as cyanogenic
glycosides.

A cyanogenic glycoside is a compound containing sugar and

having the capacity of producing prussic acid or hydrocyanic acid
(Halstead, 1977).

Other members of this family include prunasin, lina-

marin, sambunigrin, lotusin and dhurrin.
Amygdalin is one of the earliest investigated cyanogenic glycosides.

It was first isolated from bitter almonds by the French chem-

ists Robiquet and Boutron-Charland in 1830.

Its chemical properties

were first worked out by Liebig and Wohler (1837) where they indicated
that amygdalin was hydrolyzed with the evolution of benzaldehyde and
hydrogen cyanide by an enzyme preparation from bitter almonds, which
they called "emulsin".

The word "amygdalin" is derived from the Greek

word "amygdale", meaning almond.

Amygdalin is listed in the Merck

Index (1976) and is described as D-mandelonitrile-B-D-glucosido-6-BD-glucoside.

The empirical formula of amygdalin is

molecular weight is 457.42.
5.95%, N 3.06%, and 0 38.47%.

c 20 H27 No 11

and its

The elemental composition is C 52.51%, H
(See Figure 1 for the molecular struc-

ture).
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FIGURE 1.
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The term amygdalin is often used interchangeably with the word
Laetrile.

Laetrile is the form of amygdalin which is currently being

used by cancer patients seeking therapeutic benefits.

However, amyg-

dalin and Laetrile are not chemically synonymous compounds.

In 1950,

Krebs, Jr. coined the term Laetrile by combining the last five letters
of the suffix -nitrile with the first three letters of laevorotary,
since the compound was a laevorotary nitrile (Manner et al., 1978).
In the Merck Index (1976), Laetrile is defined as 1-mandelonitrile-Bglucuronic acid.

It has an empirical formula of c 14 H15N0 7 and a mole-

cular weight of 309.27.

The elemental composition is C 54.37%, H

4.89%, N 4.53% and 0 36.21%.
ture).

(See Figure 2 for the molecular struc-

Laetrile may be synthesized by the hydrolysis of amygdalin and

oxidation of the resulting 1-mandelonitrile with platinum black; by
the condensation of mandelonitrile with glucuronic acid; or by the
condensation of mandelonitrile with glucose and subsequent oxidation
(Krebs and Krebs, 1958).

Although some confusion arises between the

use of the two terms amygdalin and Laetrile, Krebs, Jr. designates
the term Laetrile to refer to any beta-cyanogenic glucosides which include amygdalin and any of its chemical derivatives (Halstead, 1977).

NATURAL SOURCES OF AMYGDALIN
Amygdalin is most commonly found in members of the Rosaceae
(rose) family.

It is found in large quantities in the seeds of apples

and pears and in the kernels, bark, and leaves of apricots, bitter almonds, wild and domestic cherries, peaches and plus (Lewis and Elvin-
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FIGURE 2.

Laetrile
COOH
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Lewis, 1977).

In addition to the seeds and kernels above, cyanogenic

glycosides are also present in millet, cassava, maize, sorghum, field
bean, lima bean, bamboo, sugar-cane, kidney bean, sweet potato, lettuce and linseed as well as 150 other foods.

Table I gives a more

complete listing.
Cyanogenic glycosides can be found in a wide range of plants.
Tableii presents a selected number of these plants.

A great number

of genera may also be found in the allied Fabaceae (pea family), as
well as in the totally unrelated Poaceae (grass family).

Thus, in

terms of phylogeny, the cyanogenic glucosides exhibit a wide and repeatedly independent origin (Lewis and Elvin-Lewis, 1977).
Extraction of amygdalin is a relatively simple procedure. Apricot kernels are first ground up and then defatted using ether as a
solvent.
cooled.

The defatted residue is boiled in alcohol, filtered and
The amygdalin is then separated from this residue and recrys-

tallized.

It is estimated that 33 kernels are needed for each 500 mg

tablet and 200 kernels for 3 grams of the intravenous formulation
(Holden, 1976).
SUGGESTED MECHANISMS OF ACTION OF AMYGDALIN
Krebs, Jr. introduced the compound Laetrile in the early 1950's
(Krebs, Jr. et al., 1958).

He claimed it to be a beta-glucuronide

analog of amygdalin, in which the gentiobiose portion of amygdalin
was replaced by a glucuronic acid molecule.

He postulated that this

molecule could be hydrolyzed by the enzyme beta-glucuronidase thereby,
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TABLE I.

Foods containing amygdalin (from

Timms~

al.).

BEANS

KERNELS OR SEEDS OF

Broad Bean (Vicia Faba)
Burma Beans
Chick Peas
Lentils (sprouted)
Lima
Mung Beans (sprouted)
Rangoon
Scarlet Runner

Apple
Apricot
Cherry
Nectarine
Peach
Pear
Plum
Prune

BERRIES

NUTS

Almost all wild berries
Blackberry
Chokeberry
Christmas berry
Cranberry
Elderberry
Raspberry
Strawberry

Bitter Almonds
Macadamia Nuts

FRUITS_~~

SEEDS
Chia Seed
Flax Seed
Sesame Seed
MISCELLANEOUS

GRASSES
Acacia
Alfalfa (sprouted)
Aquatic Grass
Johnson Grass
Milkweed
Sudan Grass
Tunus Grass
Velvet Grass
Wheat Grass
White Clover
GRAINS
Oat Groats
Barley
Brown Rice
Buckwheat Groats
Chi a
Flax
}til let
Rye
Vetch
Hheat Berries

Bamboo Shoots
Fuschia Plants
Sorghum Plant
Hild Hydrangea
Yew Tree (needles; fresh leaves)
*Contain the highest concentration of
amygdalin.
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TABLE II. Important plants containing cyanogenic glycosides, arranged
phylogenetically (from Pammel).
Angiosperms: Dicotyledons
Q1ENOPODIACEAE.

Suckleya

PASSIFLORACEAE.

Adenia, Passiflora

EUPHORBIACEAE.

Manihot, Stillingia

ROSACEAE.

Cercocarpus, Cotoneaster, Eriobotrya,

~alus,

Prunus, Pyrus,

Rhodotypos
FABACEAE.

Acacia, Cassia, Colichos, Lotus, Phaseolus, Trifolium, Vicia

SAXIFRAGACEAE.
MYRTACEAE.

Hydrangea

Eucalyptus

LINACEAE.

Linum

OLACACEAE.

Ximenia

CAPRIFOLIACEAE.
BIGNONIACEAE.
ASTERACEAE.

Crescentia
Ageratum, Bahia, Florestina

Angiosperms:
JUNCAGINACEAE.
POACEAE.

Sambucus

Monocotyledons
Triglochin

Cynodon, Glyceria, Holcus, Panicum, Sorghum, Zea

14
releasing its constituent parts: hydrocyanic acid and benzaldehyde.
It has been substantiated for some time now that tumor tissue
contains a higher concentration of beta-glucuronidase (Fishman and
Anlyan, 1947).

Krebs therefore proposed that Laetrile was releasing

cyanide selectively at the site of the cancer due to hydrolysis by
beta-glucuronidase (Krebs, 1967).

However, this claim was disproved

as it was shown that Krebs' Laetrile was actually the same as amygdalin
which is not broken down by beta-glucuronidase.

It has been shown that

the hydrolysis of amygdalin is accomplished by the enzyme beta-glucosidase (Haisman and Knight, 1967).

Using chromatographic analysis, they

indicated that the enzymatic hydrolysis of amygdalin by beta-glucosidase occurs in three steps: first the amygdalin is hydrolyzed to prunasin (D-1-mandelonitrile-B-glucoside) and glucose; next, prunasin is
hydrolized to D-1-mandelonitrile and glucose; finally, the D-1-mandelonitrile is converted to hydrocyanic acid.

Refer to Figure 3.

With this in mind, Krebs then made an alteration in his "cyanide
theory" (Greenburg, 1975; Halstead, 1977).

He proposed that amygdalin

was first being converted to a glucuronide derivative in the liver,
which is then circulated to the tumor site where it undergoes hydrolysis by the enzyme beta-glucuronidase, thereby releasing its hydrocyanic
acid.

This process would require two hydrolytic cleavages by liver

beta-glucosidase followed by the conjugation of the resulting mandelonitrile with glucuronic acid by UDP glucuronosyl transferase, but this
exact process has not been experimentally demonstrated (Halstead, 1977).
However, it has been shown that glucuronide formation does occur in the

15

FIGURE 3.

Degradation of amygdalin.
AMYGDALIN

+

(beta-glucosidase)

MANDELONITRILE-GLUCOSDIE + GLUCOSE
(PRUNASIN)
HzO
+
(beta-glucosidase)
MANDELONITRILE + GLUCOSE

+

(hydroxynitrilase)

HCN + BENZALDEHYDE
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liver and to a lesser extt:tent in the intestines and kidneys (Levvy and
and Leskinen, 1970; White et al. , 1973) ..

Conchie, 1966; Mlettlnen

In

addition, research done bdby Fishman and Anlyan (1947) demonstrates that
beta-glucuronidase is pre9esent in cancerous tissue of the breast, uterus,
stomach, mesentery, abdomonninal wall and esophagus about 100-3600 times
higher than non-cancerouszs tissue.
Currently, Krebs'

version of amygdalin's mechanism of action is

as follows: cancer cells
glucosidase, and little

have unusually high concentrations of beta-

~

o~oor

no rhodanese (the enzyme which detoxifies

cyanide, producing thiocyoyyanate).

The cyanide, being selectively re-

leased at the tumor site, ,, then exerts its cytotoxic effects.
by

Manner~

al. supports

2S

Krebs' claim.

Research

They showed that there is a

higher concentration of beC>eta-glucosidase in the mammary tumor and the
liver of tumor and non-tumLJmor bearing mice in comparison with the brain
and muscle tissue of both n

tumor and non-tumor bearing mice.

in vitro experiments have

repeatedly shown the inability of cancer

~

cells to release cyanide fi

Hmvever,

from amygdalin within a reasonable incubation

time (Hodges, 1974).
An alternative propqoposal for amygdalin's action is that it is
hydrolyzed to hydrocyanic
the intestine or possibly

acid at sites other than the tumor, such as
v

the liver.

It has been established scientif-

ically that amygdalin is ij indeed hydrolyzed in the intestinal lumen by
bacterial enzymes (Newton

net al., 1981; Carteret al., 1980).

The high

beta-glucosidase content oo of gut bacteria explains amygdalin's greater
oral toxicity. According t•j to this proposal, after amygdalin is hydrolyzed
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in the gut it is absorbed into the lymph and portal circulations, creating a low serum cyanide level which is non-toxic to the host, but to
which tumor tissue is selectively sensitive.
BETA-GLUCOSIDASE
Beta-glucosidase (EC 3.2.1.21) is known chemically as B-D-glucoside glucohydrolase.

It is a hydrolytic enzyme with an optimum pH of

4.4 to 5.0 (Barman, 1969).

It is a lysosomal enzyme and may be found

in varying amounts in animal tissues (Manner et al., 1978).

The ter1n

emulsin was originally used to designate this enzyme, but later work
showed that emulsin was a mixture of enzymes containing, among others,
the specific enzymes beta-glucosidase and beta-oxynitrilase.

Beta-

glucosidase is specific for the beta-D-glucoside linkage upon which it
exerts its hydrolytic action (Greenberg, 1975).
BETA-GLUCURONIDASE
Beta-glucuronidase (EC 3.2.1.31) is known chemically as B-Dglucuronide glucuronohydrolase.
timum pH of 4.3 to 5.0.

It is a hydrolytic enzyme with an op-

This enzyme attacks all the natural B-D-gluco-

siduronates whether glycoside- or acylal-linked, aliphatic or aromatic,
however, it is without activity on A-glucuronides of B-glucosides
(Barman, 1969).

It is a lysosomal enzyme and is universally distrib-

uted in mammalian tissues.

It is believed that this enzyme is under

endocrine control, but its function in the body remains obscure
(Conchie et al., 1961).

Levvy and Marsh (1960) indicated that B-glu-

curonidase plays a role in the catabolism of mucopolysaccharides.

It

also appears to be associated with an increase in cell proliferation
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(Kerr et al., 1949).

Fishman and Anlyan (1947) believe that elevated

B-glucuronidase is probably a characteristic of malignant cells, but
that high B-glucuronidase activity in a tissue does not necessarily
imply malignant change.
RHODANESE
Rhodanese (EC 2.8.1.1) is known chemically as thiosulphate sulphurtransferase.

It is a mitochondrial enzyme and belongs to a group

of enzymes called transferases (Barman, 1969).

Dog liver rhodanese is

thermolabile, being inactive at 56°, and has optimum activity at about
body temperature (38°) and pH 8. 3 (Hilliams, 1959).

Rhodanese catalyzes

the formation of thiocyanate from thiosulfate and cyanide.
The main pathway for cyanide detoxification is conversion to
thiocyanate.

Rhodanese is specific for hydrogen cyanide and converts

it very rapidly in the presence of sodium thiosulphate or colloidal
sulphur into thiocyanic acid.

As can be seen in Figure 4 when rhodan-

ese is activated with sodium thiosulphate, it binds a sulphur atom in
a charge-transfer complex to the indole nucleus of tryptophan.

Thio-

cyanate is then formed by a nucleophilic attack of cyanide on the sulphur-rhodanese complex (Ferris, 1970).

Thus, rhodanese has the ability

to neutralize hydrogen cyanide (Osuntokun, 1970; Montgomery, 1969; Oke,
1969).
Cyanide detoxification in the animal body was first shown by
Lang (1933) who demonstrated that after the injection of cyanide or of
aliphatic nitriles in the rabbit, an increased amount of thiocyanate

19

FIGURE 4.

E

Cyanide detoxification by rhodanese.

+ ssof

ES + CN(E

-+

ES + so~-

-+

E + seN-

rhodanese)
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was excreted in the urine.
tissue except in the blood.

Rhodanese is present in nearly all animal
Rosenthal (1948) and Westley (1973) found

spleen and kidney cancer cells to have a lower concentration of rhodanese in comparison to the liver.

In the dog, the liver being a major

detoxification organ, contains the major part of the body's supply of
rhodanese.

Lang (1933) found that the amount of liver rhodanese varies

from one species of animal to another.

According to Lang the rabbit

has twenty times as much of the enzyme per 100 grams as does dog liver,
and the cow ten times as much.

This could be attributed to the fact

that the rabbit and the cow are herbivorous.
as much of the enzyme as the dog.

The human has three times

Data from Himwich and Saunders (1948)

suggest that even though the liver undoubtedly plays a major role in
removing cyanide, detoxification probably occurs in all parts of the
body.

They also calculated that the whole liver of a dog can theoreti-

cally detoxify about 4015 grams of cyanide and the total skeletal muscles 1763 grams to thiocyanate within 15 minutes.

However, because the

fatal dose of cyanide is so relatively small, they suggest that availability of sulphur, not quantity of enzyme present, is the limiting
factor in the in vivo detoxification.
THE USE OF CYANIDE AGAINST CANCER
Since the late 1920's cyanide has been tested as an anti-neoplastic agent.

Cyanide combines and forms a complex with iron (III)

and other metals present in the respiratory enzyme systems of the cell.
Very low concentrations of cyanide can inactivate the cytochrome oxidase enzymes which catalyze oxidative phosphorylation, and the main
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supply of energy to the cell ceases.

Hydroxycobalamin (Vitamin B 12 )

and methemoglobin (iron (III) haemoglobin) also form complexes with
cyanide.

These two substances bind cyanide as strongly as the cyto-

chromes and have been used in the treatment of cyanide poisoning
(Ferris, 1970).
Karczag (1928) found that with increasing doses of cyanide he
could desensitize mice to the muscle cramping effects of KCN.

Dosages

of KCN administered to mice over periods of weeks and months influenced
neither the longevity, the growth, the weight gain, lactation or any
other biological process of normal animals.

Karczag then inoculated

these animals with Ehrlich Ascites Mouse Carcinoma and continued the
administration of KCN.

He found that the average life span of the

treated animals was significantly prolonged over the controls, that
tumor growth was slowed, and that 18% of the treated animals had a
complete remission.

He also noted no evidence of cyanide toxicity.

Other studies using cyanide against cancer have been carried
out.

Maxwell and Bischoff (1933) exposed animals bearing transplant-

able tumors (Sarcoma 180, Walker 256 and R-10 sarcoma) to an atmosphere
containing HCN (4%) for 5-6 hours daily during the life of the tumor.
Although some animals sometimes showed anoxia and prostration there is
no mention of chronic toxicity or mortality in treated animals.

They

conclude that exposure to hydrogen cyanide resulted in a decrease in
the rate of tumor growth.

A study carried out by Perry (1935), using

the Jensen Sarcoma system of rats, also tested CN administered by inhalation.

However, a large number of the treated animals died as a
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result of toxic effects, although all treated animals, alive and dead,
showed marked tumor retardation.

She concluded that the range of the

effective dose was limited and too close to the lethal dose to be practical.

More recently, a study was performed by Brown et al._ (1960) who

used anesthesia to counter CN toxicity.

Their results showed that NaCN

administered via IV perfusions in several doses between 0.75 and 1.5
mg/kg could produce life prolongations of 15-85% in Ehrlich Ascites
Mouse Carcinoma, of 70% in Sarcoma 180 of rats, and in trials on 18
dogs with spontaneous tumors, produced several apparent cures and a
number of significant life prolongations, all without apparent acute or
chronic toxicity.

They obtained better results with those animals

treated most frequently.

They also gave results on limited clinical

trials on seven terminal patients with gynecological cancer.
tected no observable delayed clinical toxicity.
any clinical changes in these patients.

They de-

But they did not find

However, the patients that

were selected for the study were those in whom the disease was considered too far advanced to be amenable to the usual form of therapy and
they were given only one 5-15 minute IV perifusion of .75-1.0 mg/kg.
TOXICITY STUDIES ON AMYGDALIN
As with any drug the toxic effects of amygdalin are governed by
the size of the dose and the method or route of administration.

A

large number of toxicity studies has been carried out with amygdalin,
however there is a great deal of inconsistency in the results obtained
from them.

Some of this discrepancy can be attributed to the mode of

administration.

It is well known that high doses given orally have not
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proven to be as safe as intramuscular or intravenous injections of
equally high doses

(Manner~

al., 1978).

According to Krebs (1970)

amygdalin given orally could be 40 times more toxic than parenterally
administered doses.

Trube-Becker (1965) estimated that 50-70 raw al-

mond kernels would have to be eaten to provide a lethal dose to adults
and as few as 7-10 almonds for a child.

However, it has been shown

that adult mice could live in perfect health to extreme old age when
their diet consisted of fifty percent defatted aprical kernels (Griffin,
1974).

Schmidt et al. (1978) found that

~vhen

dogs were given oral doses

of Laetrile along with uncooked foods containing B-glucosidases there
was a 60% mortality rate.

Another study reported by the Cancer Commis-

sian of the California Medical Association (1953) indicated that amygdalin administered to mice via gastric intubation was found to be safe
at all doses below 300 mg/kg but once the doses reached 400 mg/kg or
greater, death occurred in a matter of minutes to one hour.

Stock et

al. (1978) noted that oral dosages of amygdalin at 500 mg/kg/day were
lethal while 250 mg/kg/day was tolerated for at least 19 doses.
The greater toxicity of orally ingested amygdalin is attributed
to the presence of the gastrointestinal flora which contain the enzyme
beta-glucosidase.

Studies by Carter et al. (1980) showed that

~vhen

conventional rats were given single oral doses of amygdalin (600 mg/
kg) they usually died within 2 to 5 hours.

On the other hand, germ

free rats did not exhibit any visible signs of toxicity after receiving the same dose of amygdalin.
Newton et al.

(1981)

Another study was carried out by

to determine

the

role

of

the

bacterial
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flora of the gut in hydrolyzing amygdalin.

Using rats, they found the

LD 50 of amygdalin to be approximately 522 mg/kg of body weight.

'How-

ever, when rats were pre-treated with the antibiotic Neomycin which reduced the gastrointestinal flora, the rats became less susceptible to
amygdalin's toxicity.

A number of isolated cases of oral amygdalin toxicity have been
found when there was accidental ingestion of too many kernels. Townsend
(1975) reports of a 34 year old man who ingested approximately 48 kernels and soon thereafter exhibited some symptoms of toxicity.

He also

states that the minimum number of kernels need to induce illness or
death is not known.

It should be noted that in a few places in the

world, there are certain strains of apricot trees that produce seeds
containing ten times the concentration of amygdalin found in those
trees grown in the United States (Griffin, 1974).

Some of these trees

may be found in Turkey where it is culturally acceptable to eat apricot
kernels.

In 1964, a Turkish paper reported nine cases of cyanide pois-

oning, with two fatalities, from apricot seed ingestion during the period 1957-1962 (Sayre and Kaymakcalan, 1964).

It has been reported that

five to thirty apricot kernels eaten through the day may be a sufficient preventative amount, but they should never be taken all at one
time (Kirschman, 1979).

Krebs (1967) suggests a minimum daily intake

of fifty milligrams of amygdalin.

The average apricot kernel in the

United States contains approximately four to five milligrams of amygdalin.

Thus, to obtain Kreb's recommended dose at

50

mg,

one would

have to ingest ten to twelve apricot kernels per day (Griffin, 1974).
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Other routes of amygdalin administration have proven to be far
less toxic.

Two similar studies were carried out in 1975 administ.ering

amygdalin intraperitoneally (Laster and Schabel, 1975; Wodinsky and
Swiniarski, 1975).

Wodinsky and Swiniarski reported that amygdalin MF

was non-toxic for tumor-bearing mice when injected at a level of 64 mg/
mouse/day for 9 days, and that B-glucosidase could also be administered
safely at a dose level of 0.2 mg/mouse.

They observed toxicity only

when B-glucosidase was administered before doses greater than or equal
to 100 mg/kg of amygdalin MF.

Studies by Laster and Schabel (1975)

show that amygdalin MF alone was less toxic than when given with the
activating agent, B-glucosidase.

When only amygdalin MF was adminis-

tered to mice intraperitoneally for nine days it produced 60%mortality,
at a dose of 500 mg/kg, 30% mortality at 355 mg/kg, and no deaths at
220 mg/kg.

However when B-glucosidase (10 mg/kg/dose) was given in

combination with the amygdalin MF, the highest level that could be tolerated by normal mice without exceeding the LD 10 was 53 mg/kg/dose.
Experiments by Hill

~

al. (1976) were carried out using intraperiton-

eal injections of amygdalin in mice.

Their results indicate that at

doses ranging from 50-500 mg/kg for 4 days there were no signs of toxicity, but when the dose was increased to 2000 mg/kg for 4 days there
was a 5% death rate.

Another experiment using intraperitoneal doses

of amygdalin in mice was carried out by Stock et al. (1978).

They

noted that there was no toxicity from properly executed doses of amygdalin as high as 1000 mg/kg/day from 6-28 injections and in one experiment as high as 8000 mg/kg/day for 6 injections.

Contrary to Stock's

results are data from Khandekar and Edelman (1979) who report that
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amygdalin given to Fischer 344 rats in doses of 250, 500, and 750 mg/kg
intraperitoneally for five days, caused mortalities of 30.8%, 44.1%,
and 56.8%, respectively.

However,

Stock~

al. (1978) responded to

these data in a letter to the editor where he stated, "faulty intraperitoneal injections may have caused damage to the intestine by releasing the enzyme B-glucosidase from the bacterial flora, which quickly liberated cyanide from the amygdalin, causing mortality."
A study was performed by Manner et al. (1977) where they injected Jax C57 Bl/KsJ mice intramuscularly with doses ranging from
1000-2500 mg/kg for 15 days.

They found that daily doses of up to

2000 mg/kg could be used without danger of toxicity.

Amygdalin used

in cancer therapy on adult humans has been administered in dosages of
up to 70 grams by combined oral and parenteral routes without ill effects (Rubin, 1977).

More recently, a pharmacologic test was carried

out by the National Cancer Institute to look for possible toxic effects
in a small number of cancer patients.

Six patients entered the study;

three received an IV formulation of Laetrile and three received it
orally.

The patients were also given foods containing the enzyme B-

glucosidase.

They were all treated as in-patients and were closely

monitored with blood and urine samples for cyanide and thiocyanate
levels as well as any clinical evidence of cyanide toxicity.

The re-

sults showed that five of the six patients experienced no toxic effects
that could be directly or indirectly ascribed to Laetrile therapy.
patient showed clinical evidence of toxicity only after eating large
quantities of raw almonds (Henney, 1980).

One
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PREVENTION STUDIES WITH AHYGDALIN
There are very few controlled laboratory experiments using amygdalin for cancer prevention.

In reviewing the literature only one set

of two prevention studies using spontaneous tumors in mice could be
found (Stock et al., 1978).

Both of these experiments were performed

by Stock's co-worker, Kanematsu Sugiura.

In the first prophylaxis ex-

periment he used CD 8 F 1 mice, a strain which develops spontaneous mammary tumors.

Mice in the experimental group received daily intraperi-

toneal injections of amygdalin 6 times per week at a dosage of 1000 mg/
kg/day.

The control group received 0.5 ml injections of physiological

saline.

Although five experimental animals were killed accidentally by

the injection of amygdalin into the intestine or in the uterine horn of
pregnant mice, he still obtained interesting results.

In 30 control

animals 81% developed lung metastases and 82% tumors.

In 24 experi-

mental animals 17% developed lung metastases and 72% tumors.

The aver-

age number of days for tumor development were 411 and 449 in control
and experimental mice, respectively.

The second prophylaxis experiment,

also performed by Sugiura, tested amygdalin against spontaneous leukemia in

&~R

mice.

The mice were divided into 2 groups, one to receive IP

injections of 0.5 ml saline daily six times per week and the other to
receive 2000 mg/kg/day of amygdalin.

His findings show that in none of

the mice was there prevention of the development of leukemia or significant increase in the survival of the mice.

However, they do state

that it might have been less of a challenge to the amygdalin if younger
mice further from the occurrence of leukemia had been used.
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Only t'vo other similar laboratory experiments on cancer prevention with amygdalin could be found.

However, in these studies trans-

plantable tumors were used instead of spontaneous tumors.
study by Reitnauer which was published in 1974.

One was a

He pretreated 20 out

of 40 H strain mice with bitter almonds which were taken in addition to
their standard feed in a free food .choice.

After fifteen days of pre-

treatment, all 40 mice were innoculated with 10 6 Ehrlich Ascites cells.
The 20 control mice lived an average of 21.9 days follmv-ing the transplant.

The 20 mice who received bitter almonds throughout the experi-

ment lived an average of 25.8 days (p < 0.05 by t-test).
periment was carried out in France in 1977 by Metianu.

Another exTen controls

and 10 mice treated subcutaneously two to three times per week for 20
to 25 days with 500 mg/kg of amygdalin were injected with 5 x 10 8 cells
of an adenocarcinoma adapted for mice.

The experimental group lived an

average of 58 days past the time of tumor take, while the control group
averaged 21 days survival.

To see if the results could be replicated,

he repeated the same experiment and found the experimental group to
live 47 days past the time of tumor take, and 27 days survival for the
controls.

He obtained less noticeable results with higher doses, and

observed no effect with amygdalin at 100 mg/kg.
USE OF THE FE:HALE C3H/HeJ HOUSE
Among all of the laboratory mammals, the common mouse is the
most widely used (Green, 1966).

Advantages of using themouse include

easy availability of inbred strains from national or regional stock
centers (i.e. Jackson Laboratories), the large amount of information
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known on their genetics and biology, low cost, and small size, which
minimizes care and space.

The latter two advantages are of particular

importance when carrying out large scale, long term (2 years) prevention studies such as this one.
The rodent tumor selected to evaluate the anti-tumor properties
of naturally occurring amygdalin was the spontaneous murine mammary
adenocarcinoma.

Mammary tumors (in breeding females) are the most com-

mon tumors of inbred strains of mice and are probably the most completely studied of all tumors (Dunn, 1959).

Spontaneous mammary tumors from

inbred strains of mice form one of the most useful groups of neoplasms
for certain investigations in the field of cancer research (Auduvant
and McEleney, 1940).

Advantages of using this tumor include accessi-

bility to palpation and predictable frequency in a number of inbred
strains.

Therefore, the mammary tumor has been an invaluable tool for

investigations in genetic, viral, hormonal, chemotherapeutic, nutritional and other facets on cancer research (Green, 1966).
Another important reason for using this rodent tumor is that it
is a spontaneous type of tumor.

There seems to be some basis for con-

sidering spontaneous tumors to be a truer model of the situations of
medical interest, both in growth characteristics and in treatability
(Martinet al., 1975).
The mouse chosen for this study is the female C3H/HeJ strain.
This strain of mouse was selected because it has been used previously
by investigators in our laboratory (Manner et al., 1978).

Also, the

C3H strain of mouse is typical of one of the high-incidence strains
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produced through brother-and-sister mating.

In breeding females, spon-

taneous mammary tumors are usually observed at about

8~

months and the

average duration of life after the tumor is 6 to 7 weeks (Lippincott et
al., 1942).

Thus, strain C3H females are useful in studies on the oc-

currence of spontaneous mammary cancer in mice since the high incidence
supplies satisfactory controls for experiments in the inhibition of the
tumors (Auduvant and McEleney, 1940).

CHAPTER III
MATERIALS AND METHODS
PREVENTION STUDY
For the prevention experiment, one hundred and fifty female C3H/
HeJ mice, Mus musculus, were obtained from Jackson Laboratories in Bar
Harbor, Maine.

These mice were retired breeders and when received were

approximately 8 months of age.
proximately 18 months.

These mice have a mean life span of ap-

Female C3H/HeJ mice are genetically bred for

approximately a 60% maximum cumulative incidence of mammary tumors
(Jackson Laboratories, 1979).
grams.

The average weight of the mice was 30

Initially, these mice were housed 4 in a cage (plastic shoe-box

type) containing an inert bedding called Sanicel.
The environmental conditions were kept constant.
were checked daily and cages changed routinely.

Water bottles

Humidity was kept be-

tween 50-55%; room temperature, 23 ± 2° C; photoperiod twelve hours of
light and twelve hours of darkness.

All animals received standard

Purina Mouse Chow and tap water ad libitum.
This study was initiated on September 17, 1979.

Prior to ex-

perimentation, all animals were screened by palpation for the presence
of spontaneous mammary tumors.
used at the start of this study.

Only those mice without any tumors were
Forty-five control animals were
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maintained on the standard diet above.

Eighty experimental animals re-

ceived apricot kernels ad libitum in addition to their standard diet.
The apricot kernels were obtained from American Nutrition Products,
Thousand Oaks, California and were stored at 5° C.

Apricot kernels are

the primary source of amygdalin and on analysis contain 2 to 3% amygdalin and also substantial amounts of protein, unsaturated fatty acids,
and minerals (Kirschman, 1973).

Evidence of apricot kernel consumption

by the animals was noted by observation.
The animals were palpated thoroughly each day until a tumor was
found.

Once a tumor was found, the length of time for appearance was

recorded, and thereafter, the mice were caged separately and observed
for tumor growth or recession, longevity, and general appearance.

Ex-

perimental animals with mammary tumors continued to receive apricot
kernels ad libitum.

All animals were maintained until death, so that

a mortality rate could be established.
TOXICITY STUDIES
Another study was carried out to investigate for any possible
toxic effects that might be incurred when chronic low doses of amygdalin
are administered via the oral route.
Forty female C3H/HeJ mice without tumors were used for this
study.

They were caged separately and fed Purina Mouse Chow and tap

water ad libitum.

The mice were divided into four groups of ten.

The

first group received a daily dosage of natural amygdalin dissolved in
their drinking water.

The amount of amygdalin used was equivalent to
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3% (the approximate amount of amygdalin in apricot kernels).

Another

group received a daily dosage of natural amygdalin equivalent to 250mg/
kg.

The third group received daily dosages of natural amygdalin which

were increased each day until toxic effects were noted.

In the latter

two groups the amygdalin was dissolved in distilled, deionized water
and administered orally via gastric incubation after methods of Simmons
and Brick (1970).

The last group was maintained as a control group and

received distilled, deionized water via gastric intubation in a dosage
volume equivalent to the experimental groups.

The amygdalin used was

obtained from Sigma Chemical Company, St. Louis, Missouri and was approximately 99% pure.

The amygdalin solutions were prepared fresh

daily.
All animals were weighed at the beginning of the experiment and
again at the end and weight changes were noted.

Observations were made

twice daily, and all signs of toxicity were recorded.

CHAPTER IV
RESULTS
PREVENTION STUDY
The mice in this study were categorized into t'vo groups.

Group

1 (controls) represents the mice that did not receive apricot kernels
and Group 2 (experimental) represents the mice that did receive apricot
kernels.
The number of mice that formed spontaneous mammary tumors was examined in both groups.

The results can be seen in Figure 5.

In the

control group, 77.8% of the animals formed tumors, and in the experimental group 78.8% of the animals formed tumors.

This does not repre-

sent a significant difference.
The mean time for the tumors to develop was also examined.
results are represented in Figure 6.

The

The mean number of months requir-

ed for tumor formation in the control group was 5.9 ± 3.5 months and in
the experimental group it was 6.8 ± 3.6 months.

This was not found to

be significantly different.
This experiment also evaluated the effects of apricot kernels on
the mean life span of the mice.

Figure 7 shows a comparison between the

non-tumorous control and experimental animals and the tumorous control
and experimental animals.

Non-tumorous mice in the control group lived

a mean of 18.8 ± 3.3 months and those in the experimental group lived a
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FIGURE 5.

Percentage of tumorous mice in control and experimental
groups.
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FIGURE 6.

Hean number of months required for tumor formation.
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FIGURE 7.

Hean life span of female C3II/HeJ mice.
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mean of 18.0 ± 2.9 months.

Tumorous mice in the control group lived a

mean of 16.6 ± 3.8 months and tumorous mice in the experimental gr9up
lived a mean of 17.6 ± 3.5 months.

The difference in the mean life span

of mice in either of these groups was not found to be significantlydifferent.
To ensure thorough evaluation of the data, comparisons were made
between the mean life span of tumorous mice in the control group and
non-tumorous mice in both the control and experimental groups.

Compar-

isons were also made between the mean life span of tumorous mice in the
experimental group and non-tumorous mice in the control and experimental groups.

In both of these comparisons, there could be found no sig-

nificant difference in the mean life span of the mice (see Figure 8).
TOXICITY STUDY
The results from the toxicity study are given in Table III.

In

mice given a 3% solution of amygdalin, seven out of ten mice died after
the first day and the three remaining mice were dead after the second
day.

This represents a cumulative mortality of 100%.

When amygdalin

was administered in an oral dose of 250 mg/kg/day for fifteen days,
there was one death out of ten animals.

When the dose was escalated to

400 mg/kg/day for fifteen days there were five deaths after one day;
five more deaths after two days.

This represents a cumulative mortali-

ty of 100% and suggests that the LDso of orally ingested amygdalin lies
approximately around this dose.

In the control group which received

distilled, deionized water by gastric intubation, there was one death
out of ten animals.
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FIGURE 8.

Comparison between tumorous and non-tumorous control and
experimental mice,

25.0

20.0

U)

~

15.0

f-

~

10.0

5.0 ..

D

II
•

control mice with tumors

experimental mice with tumors
control mice without tumors

~experimental

mice without tumors

TABLE III.

Group

Effects of orally ingested amygdalin on mortality of female C3H/HeJ mice.

Dose of
Amygdalin

No. of
Animals

1

2

A

3% Solution

10

7

3

B

250 rug/kg

10

0

0

c

400 rug/kg

10

5

5

D

Controls

10

0

0

3

4

Mortality Distribution
(Day)
5 6 7 8 9 10 11 12

13

14

15

Mortality %
100

0

1

0

0

0

0

0

0

0

0

0

0

0

10
100

1

0

0

0

0

0

0

0

0

0

0

0

0

10

~

0

CHAPTER

V

DISCUSSION
These studies on the toxicity and cancer preventive effects of
orally ingested natural amygdalin were performed to help provide further information about the importance of this substance in everyday
human use.

They are important because it is estimated that 70,000

people in the United States alone have used amygdalin in an attempt to
fight cancer and 22 states have legalized its use (Sun Times, 1981).
Also, apricot kernels and similar pits and seeds are sold in health
food stores and are widely promoted as having disease preventive or
curative properties (Townsend and Boni, 1975).
In the prevention study, apricot kernels were given to female
C3H/HeJ mice along with their standard feed in a free food choice.

The

experimental design was similar to that of Reitnauer (1974) and should
simulate the same procedures that are used in humans for cancer prevention.

One drawback with this design, however, is that there is no way

of determining with any degree of certainty the precise amount of amygdalin that was ingested by the mice.

Thus, the possibility exists that

some of the mice in the experimental group may not have eaten the apricot kernels at all.

However, based on observations there was positive

evidence of consumption of the apricot kernels by all of the mice.
Apricot kernels were chosen because they are the primary source of
41
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amygdalin and are commonly used by proponents of amygdalin for prevention of cancer.
The results fromthispreliminary prevention study appear to indicate that apricot kernels do not prevent the formation of spontaneous
mammary tumors in female C3H/HeJ mice, nor do they appear to prolong
the onset of tumor formation (Figures 5 and 6).

In the experimental

group, the formation of tumors was delayed by a mean of 0.93 months,
but this was not found to be statistically significant using a corrected two-tailed Student's t-test.

These data confirm the results of Stock

et al. (1978) who found that amygdalin injected intraperitoneally had
no significant preventive effect on the formation of spontaneous mammary tumors in CD 8 F 1 mice and spontaneous leukemia in AKR mice.
This study also analyzed the effects of the apricot kernels on
the longevity of the mice.

The mice in the experimental group that

formed tumors lived a mean of 0.99 months longer than those in the control group that formed tumors, but this was not found to be significantly different.

But no significant difference could be found in the mean

life span of the mice that didn't form tumors in the control and experimental groups (Figure 7).

These results seem to indicate that the

apricot kernels are not having any toxic effects which would alter the
life span of the experimental mice.
At this time it seems appropriate to mention one other factor
that may lend some error to the interpretation of the results.

When

handling the data statistically, only the mean age of the mice was
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known when they were obtained from the supplier.

Therefore, the data,

which was recorded in days, was converted to months.

This was done to

compensate for any possible sample error.
Several important assessments can be made from the data in the
toxicity studies.

In the mice that received 3% amygdalin in their

drinking water, there was a cumulative mortality of 100%.

These re-

sults are agreeable with those found elsewhere in the literature.

In

an article by Sayre and Kaymakcalan (1964) it indicates that amygdalin
present in the seed is harmless as such.

However, when the seed is

crushed and the pulp is placed in the presence of water, the catalysis
of amygdalin is enhanced and the amygdalin is broken down into its constituent parts, one of them being hydrocyanic acid.

The results of this

experiment would explain the report of a 34 year old man who developed
symptoms of cyanide poisoning after crushing up 48 apricot kernels and
mixing them with milk and honey before ingesting them (Townsend and
Bani, 1975).

These results also seem to confirm the results of Schmidt

et al. (1978) who found that sweet almonds (which contain the enzyme
B-glycosidase), amygdalin and water mixed together in a blender then
administered to dogs after various incubation times caused toxiceffects.
In a nutrition almanac by Kirschman (1979) it states, "it is not considered desirable to prepare a slurry of ground up kernels (as in a
solution of water, milk, or orange juice) and then let it stand for
long periods of time before consumption."

Thus, the results from this

present toxicity study support this statement as well as the previously
mentioned studies of Schmidt et al. and Townsend and Bani.
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The present toxicity studies also looked at the daily oral dose
of amygdalin that could be tolerated by the mice and the oral
amygdalin required to exhibit toxic effects.

dos~

of

It may be concluded from

the data that daily oral doses of amygdalin at 250 mg/kg/day are nontoxic in mice, but when the dosage is increased to 400 mg/kg/day there
is a 50% mortality rate.

These results confirm those obtained by the

Cancer Commission of the California Medical Association (1953).

Al-

though one death was found in the 250 mg/kg/day group, this was not
found to be significant when compared with the controls.

The cause of

death could be attributed to stress or trauma as a result of administering the solutions by gastric intubation.
As proposed by advocates of amygdalin, the number of apricot
kernels that should be eaten for a preventive effect is five to thirty
kernels (Krebs, 1967; Kirschman, 1979).

The average apricot kernel

grown in the United States contains approximately four to five milligrams of amygdalin (Griffin, 1974).

Using this average figure, the

amount of amygdalin in five to thirty kernels would be 25 to 150 mg/day.
For a 70 kg man, this is 0.36 to 2.14 mg/kg/day.

As mentioned previous-

ly the dose required to produce toxic effects in mice was found to be
400 mg/kg/day and since humans are seven times more sensitive to the
lethal effects of standard chemotherapeutic agents than mice (Freireich
et al., 1966) this translates into 57 mg/kg/day for humans.

Therefore,

it appears that the recommended dose of amygdalin for prevention would
not appear to be toxic in humans.

However, as in any experiment using

laboratory animals one must be extremely cautious about extrapolations
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from observations on mice directly to humans (Good, 1981).
In summary, the data presented here indicate that apricot kernels by themselves have no real important effects on the inhibition of
tumor growth in mice.

The results from the toxicity studies do show

that when natural amygdalin is ingested in biologically rational doses
it is non-toxic.

One point that should be mentioned is that the exact

amount of amygdalin that was ingested by the mice in the prevention
study was unknown, therefore the possibility exists that the dosage of
amygdalin obtained by the mice was too low to have had a preventive effect.

Future studies on naturally occurring amygdalin could be carried

out using a Mouse Chow with various known concentrations of amygdalin
incorporated into it and caging the mice separately.

That way the

amount of amygdalin consumed by the mice could be more accurately monitored.
Another explanation for the ineffectiveness of the apricot kernels in preventing tumor formation is the fact that they were the only
modality used.

In previous studies by Manner et al. (1978), it was

found that amygdalin used alone was not effective in suppressing tumor
formation, but when used in conjunction with a complete metabolic therapy program, it was found to be effective.

In light of this fact, a

future experiment on cancer prevention should be carried out using
naturally occurring amygdalin in conjunction with a complete metabolic
program.
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